Pathogenesis of Target Organ Damage in Hypertension: Role of Mitochondrial Oxidative Stress

Author： Rubattu Speranza   Pagliaro Beniamino   Pierelli Giorgia   Santolamazza Caterina   Di Castro Sara   Mennuni Silvia   Volpe Massimo  

Publisher： MDPI

E-ISSN： 1422-0067|16|1|823-839

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.16, Iss.1, 2014-12, pp. : 823-839

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Hypertension causes target organ damage (TOD) that involves vasculature, heart, brain and kidneys. Complex biochemical, hormonal and hemodynamic mechanisms are involved in the pathogenesis of TOD. Common to all these processes is an increased bioavailability of reactive oxygen species (ROS). Both in vitro and in vivo studies explored the role of mitochondrial oxidative stress as a mechanism involved in the pathogenesis of TOD in hypertension, especially focusing on atherosclerosis, heart disease, renal failure, cerebrovascular disease. Both dysfunction of mitochondrial proteins, such as uncoupling protein-2 (UCP2), superoxide dismutase (SOD) 2, peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α), calcium channels, and the interaction between mitochondria and other sources of ROS, such as NADPH oxidase, play an important role in the development of endothelial dysfunction, cardiac hypertrophy, renal and cerebral damage in hypertension. Commonly used anti-hypertensive drugs have shown protective effects against mitochondrial-dependent oxidative stress. Notably, few mitochondrial proteins can be considered therapeutic targets on their own. In fact, antioxidant therapies specifically targeted at mitochondria represent promising strategies to reduce mitochondrial dysfunction and related hypertensive TOD. In the present article, we discuss the role of mitochondrial oxidative stress as a contributing factor to hypertensive TOD development. We also provide an overview of mitochondria-based treatment strategies that may reveal useful to prevent TOD and reduce its progression.

Related content

Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction

By Mikhed Yuliya   Daiber Andreas   Steven Sebastian  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 15918-15953 (36)

MDPI

Access to resources Recommend Favorite

Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)

By Takaki Akinobu   Kawai Daisuke   Yamamoto Kazuhide  

International Journal of Molecular Sciences, Vol. 14, Iss. 10, 2013-10 ,pp. : 20704-20728 (25)

MDPI

Access to resources Recommend Favorite

The Role of Metallothionein in Oxidative Stress

By Ruttkay-Nedecky Branislav   Nejdl Lukas   Gumulec Jaromir   Zitka Ondrej   Masarik Michal   Eckschlager Tomas   Stiborova Marie   Adam Vojtech   Kizek Rene  

International Journal of Molecular Sciences, Vol. 14, Iss. 3, 2013-03 ,pp. : 6044-6066 (23)

MDPI

Access to resources Recommend Favorite

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension

By Muñoz-Durango Natalia   Fuentes Cristóbal A.   Castillo Andrés E.   González-Gómez Luis Martín   Vecchiola Andrea   Fardella Carlos E.   Kalergis Alexis M.  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 797-797 (1)

MDPI

Access to resources Recommend Favorite

Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection—The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress

By Quryshi Nabeel   Norwood Toro Laura E.   Ait-Aissa Karima   Kong Amanda   Beyer Andreas M.  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 797-797 (1)

MDPI

Access to resources Recommend Favorite